Modus Therapeutics Holding AB (publ) (STO:MODTX)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.289
-0.002 (-0.69%)
At close: Mar 6, 2026
-76.21%
Market Cap 35.15M
Revenue (ttm) n/a
Net Income (ttm) -18.54M
Shares Out 121.63M
EPS (ttm) -0.30
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 17,118
Average Volume 142,964
Open 0.289
Previous Close 0.291
Day's Range 0.282 - 0.289
52-Week Range 0.208 - 5.000
Beta 0.21
RSI 43.17
Earnings Date Feb 25, 2026

About STO:MODTX

Modus Therapeutics Holding AB (publ), a biotechnology company, develops a treatment for sepsis and septic shock in Sweden. It develops Sevuparin, a lipopolysaccharide in Phase IIa trial to treat patients with sepsis, septic shock, anemia associated with chronic kidney disease, endotoxemia, severe malaria, and other diseases involving severe systemic inflammation. Modus Therapeutics Holding AB (publ) was founded in 2011 and is headquartered in Stockholm, Sweden. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2011
Employees 2
Stock Exchange Nasdaq Stockholm
Ticker Symbol MODTX
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.